UK gene therapeutics firm files US IPO

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Equity
Equity IPOs

UK gene therapeutics firm files US IPO

Sam Kerr
July 20, 2020 12:15 PM
NYSE_PA_575x375_PA_July20_2020.jpg
The stock market continues to surge after the 4th of July Holiday during the Coronavirus Pandemic in New York City. The Dow Jones Industrial Average rose 460 points today. (NYC) | SMXRF/Starmax/PA Images

Freeline Theraputics, the UK gene therapeutics company, has filed to list in the US on the Nasdaq exchange, continuing the trend of biotech companies seeking to raise capital in the equity capital markets.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOsHealth and BiotechEquityUKUnited StatesAmericasEuropeNorth AmericaEMEASRI
SK
Sam Kerr
Gift this article